Actinium Pharmaceuticals, Inc.(ATNM)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-12-10 | SETH SANDESH Chairman & CEO | Purchase | +10,000 | +6.98%153,333 | $0.44 | $4,372 | View SEC filing | |
| 2018-12-10 | O'Loughlin Steve Principal Financial Officer | Purchase | +10,000 | +39.22%35,500 | $0.43 | $4,350 | View SEC filing | |
| 2018-11-20 | Ludwig Dale L. Chief Scientific Officer | Purchase | +10,000 | +100.00%10,000 | $0.45 | $4,499 | View SEC filing | |
| 2018-07-17 | SETH SANDESH CEO | Purchase | +10,000 | +7.50%143,333 | $0.79 | $7,900 | View SEC filing | |
| 2018-06-15 | O'Loughlin Steve Principal Financial Officer | Purchase | +12,000 | +88.89%25,500 | $0.50 | $6,000 | View SEC filing | |
| 2018-04-20 | SETH SANDESH Chairman & CEO | Purchase | +5,000 | +3.90%133,333 | $0.38 | $1,900 | View SEC filing | |
| 2018-03-01 | Shetty Ajit Director | Purchase | +22,730 | +100.00%22,730 | $0.43 | $9,774 | View SEC filing | |
| 2017-08-04 | SETH SANDESH Chairman & CEO | Purchase | +33,333 | +78.43%75,833 | $0.75 | $25,000 | View SEC filing | |
| 2017-08-04 | Ray Nitya G. Executive Vice President | Purchase | +10,000 | +100.00%10,000 | $0.75 | $7,500 | View SEC filing | |
| 2017-06-15 | Berger Mark Stanley Chief Medical Officer | Purchase | +5,000 | +100.00%5,000 | $1.11 | $5,550 | View SEC filing | |
| 2017-06-15 | SETH SANDESH Chairman and CEO | Purchase | +7,500 | +10.34%80,000 | $1.16 | $8,725 | View SEC filing | |
| 2017-06-15 | O'Loughlin Steve Principal Financial Officer | Purchase | +3,500 | +100.00%3,500 | $1.17 | $4,095 | View SEC filing | |
| 2017-01-03 | SETH SANDESH Executive Chairman | Purchase | +5,000 | +16.67%35,000 | $0.88 | $4,400 | View SEC filing | |
| 2016-12-12 | SETH SANDESH Executive Chairman | Purchase | +5,000 | +20.00%30,000 | $0.98 | $4,900 | View SEC filing | |
| 2016-09-01 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -192,927 | -3.94%4,709,561 | $1.83 | $352,372 | View SEC filing | |
| 2016-08-30 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -50,000 | -1.01%4,902,488 | $1.71 | $85,495 | View SEC filing | |
| 2016-08-17 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -9,468 | -0.19%4,952,488 | $1.72 | $16,287 | View SEC filing | |
| 2016-07-14 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -3,100 | -0.06%4,961,956 | $1.80 | $5,581 | View SEC filing | |
| 2016-07-12 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -21,990 | -0.44%4,965,056 | $1.80 | $39,582 | View SEC filing | |
| 2016-07-07 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -20,840 | -0.42%4,987,046 | $1.81 | $37,762 | View SEC filing | |
| 2016-07-05 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -148,100 | -2.87%5,007,886 | $1.81 | $268,436 | View SEC filing | |
| 2016-06-17 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -33,619 | -0.65%5,155,986 | $1.90 | $63,876 | View SEC filing | |
| 2016-06-06 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -17,790 | -0.34%5,189,605 | $2.01 | $35,716 | View SEC filing | |
| 2016-06-02 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -169,450 | -3.15%5,207,395 | $1.97 | $333,385 | View SEC filing | |
| 2016-05-31 | Memorial Sloan-Kettering Cancer Center 10% Owner | Sale | -40,068 | -0.74%5,376,845 | $1.92 | $77,061 | View SEC filing |
1-25 of 34